Signals
Platform Powered By EquityPandit

Cash Intraday
Signals

Option
Signals

Stock Future
Intraday Signals

Swing Trading
Signals

Investment
Opportunities

Stock
Signals

Join Now

Introducing UNICORN Signals

Powered By EquityPandit
4.5 Google Ratings

Gland Pharma Ltd

NSE :GLAND   BSE :543245  Sector : Pharmaceuticals
Buy, Sell or Hold GLAND? Ask The Analyst
Check Gift Nifty (SGX Nifty) Live Price to predict the market.

BSE

prev close

OPEN PRICE

volume

Today's low / high

52 WK low / high

bid price (qty)

offer price (qty)

NSE

prev close

open price

volume

Today's' low / high

52 WK low / high

bid price (qty)

offer price (qty)

28 Mar
1592.40
(-0.78%)
27 Mar
1604.85
(-1.12%)
26 Mar
1623.10
(-0.67%)
25 Mar
1634.00
(1.48%)
24 Mar
1610.20
(1.56%)
21 Mar
1585.40
(-0.39%)
20 Mar
1591.65
(0.58%)
19 Mar
1582.50
(0.20%)
18 Mar
1579.40
(1.45%)
17 Mar
1556.75
(0.12%)
13 Mar
1554.85
(-1.54%)
12 Mar
1579.10
(-1.89%)
11 Mar
1609.55
(-2.73%)
10 Mar
1654.70
(0.80%)
07 Mar
1641.55
(0.71%)
06 Mar
1629.95
(3.38%)
05 Mar
1576.60
(3.56%)
04 Mar
1522.40
(-1.07%)
03 Mar
1538.80
(-0.90%)
28 Feb
1552.80
(-4.02%)
27 Feb
1617.80
(1.25%)

Price Chart Historical Data Technical Chart

Technical Analysis

Short Term Investors

Bullish
Medium Term Investors

Very Bullish
Long Term Investors

Bearish

Moving Averages

5 DMA
Bearish

1613.03

10 DMA
Bearish

1594.5

20 DMA
Bullish

1590.03

50 DMA
Bullish

1554.32

100 DMA
Bearish

1667.43

200 DMA
Bearish

1762.74


Intraday Support and Resistance
(Based on Pivot Points) undefined |

Updated On Mar 28, 2025 04:00 PM For Next Trading Session

Pivots Classic Fibonacci Camarilla Woodie DM
R3 1677.79 1655.87 1607.15 - -
R2 1655.87 1635.38 1602.24 1653.41 -
R1 1624.14 1622.71 1597.32 1619.22 1640
P 1602.22 1602.22 1602.22 1599.76 1610.15
S1 1570.49 1581.73 1587.48 1565.57 1586.35
S2 1548.57 1569.06 1582.56 1546.11 -
S3 1516.84 1548.57 1577.65 - -

Key Metrics

EPS

68.05

P/E

23.4

P/B

2.86

Dividend Yield

1.26%

Market Cap

26,236 Cr.

Face Value

1

Book Value

556.81

ROE

9.26%

EBITDA Growth

417.45 Cr.

Debt/Equity

0.02

Shareholding Pattern

  51.83% Total Promoter Holding
32.37% Mutual Fund Holdings
5.04% FIIs
8.33% Non Institution
1.38% Insurance Companies
0% Custodians
1.05% Other Parties

Shareholding History

Quarterly Result (Figures in Rs. Crores)


Gland Pharma Ltd Quaterly Results


Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
INCOME1582.55 1579.6 1453.14 1465.49 1442.55
PROFIT191.86 192.42 143.76 163.53 204.69
EPS11.65 11.68 8.73 9.93 12.42

Gland Pharma Ltd Quaterly Results


Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
INCOME1141.25 1221.79 1060.51 1120.79 1075.85
PROFIT276.81 321.41 222.92 281.71 295.12
EPS16.81 19.51 13.53 17.1 17.91

Profit & Loss (Figures in Rs. Crores)


Gland Pharma Ltd Profit & Loss


Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
INCOME 2779.31 3871.15 4587.96 3911.98 5707.07
PROFIT 759.87 996.94 1208.44 820.62 772.05
EPS 0 60.94 73.75 47.42 46.9

Gland Pharma Ltd Profit & Loss


Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
INCOME 1017.07 1375.14 1466.37 1735.4 2243.91 2779.31 3871.15 4587.96 3903.91 4246.67
PROFIT 209.29 313.72 413.69 321.1 465.06 759.87 996.99 1208.94 815.38 1043.72
EPS 133.53 202.39 267.01 207.24 291.65 49.88 60.95 73.78 47.11 63.34

Balance Sheet (Figures in Rs. Crores)

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
SOURCES OF FUNDS :
Share Capital 16.4716.4716.4316.3615.5
Reserves Total 8,707.377,942.257,141.115,886.883,630.74
Equity Application Money000.0800
Total Shareholders Funds8,723.847,958.727,157.625,903.243,646.24
Unsecured Loans 372.174.454.7454.96
Total Debt372.174.454.7454.96
Other Liabilities177.71.731.731.732.66
Total Liabilities9,273.717,964.97,164.095,909.973,653.86
APPLICATION OF FUNDS :
Gross Block 5,011.682,294.962,081.321,430.71,347.81
Less: Accumulated Depreciation1,064.93724.41579.13476.47379.71
Net Block3,946.751,570.551,502.19954.23968.1
Capital Work in Progress237.88177.22190.75337.81188.47
Investments 00154.8700
Inventories 1,655.241,945.31,185.671,275.17756.28
Sundry Debtors 1,558.69871.391,074.81670.97601.79
Cash and Bank Balance1,839.433,770.683,093.443,005.751,325.19
Loans and Advances 591.79313.44343.3171.75163.03
Total Current Assets5,645.156,900.815,697.215,123.642,846.29
Current Liabilities 1,056.87696.12539.02458.41329.93
Provisions 110.5432.342.7553.8228.2
Total Current Liabilities & Provisions1,167.42728.42581.77512.23358.13
Net Current Assets4,477.736,172.395,115.444,611.412,488.15
Deferred Tax Assets58.7222.717.656.026.05
Deferred Tax Liability228.4106.9295.4179.980.1
Net Deferred Tax-169.68-84.21-87.76-73.88-74.05
Other Assets781.03128.96288.680.483.18
Total Assets9,273.717,964.97,164.095,909.973,653.85
Contingent Liabilities15.5822.0712.7674.711.83
Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
SOURCES OF FUNDS :
Share Capital 16.4716.4716.4316.3615.515.515.515.515.4915.67
Reserves Total 8,978.827,936.837,141.725,886.933,630.742,846.622,394.932,074.321,661.571,378.52
Equity Application Money000.080000000
Total Shareholders Funds8,995.297,953.37,158.235,903.293,646.242,862.122,410.432,089.821,677.061,394.19
Secured Loans 0000000090.07129.01
Unsecured Loans 3.664.454.7454.965.495.926.3826.9737.45
Total Debt3.664.454.7454.965.495.926.38117.04166.46
Other Liabilities20.691.731.731.732.6615.238.1339.260.370.27
Total Liabilities9,019.647,959.487,164.75,910.023,653.862,882.812,454.482,135.461,794.471,560.92
APPLICATION OF FUNDS :
Gross Block 2,579.912,294.962,081.321,430.71,347.811,219.581,054.451,005.521,020.22820.49
Less : Accumulated Depreciation 886.18724.41579.13476.47379.71290.83211.81133.94232.34171.86
Net Block 1,693.731,570.551,502.19954.23968.1928.75842.64871.58787.88648.63
Capital Work in Progress120.01177.22190.75337.81188.47123.16198.88161.15202.1192.08
Investments 2,385.748.16163.030.5500000.170.17
Inventories 1,260.211,945.31,185.671,275.17756.28911.88512.83378.72367.08321.19
Sundry Debtors 1,171.4862.841,074.81670.97601.79506.1475.21417.87350.69169.31
Cash and Bank Balance1,598.553,7673,085.83,005.21,325.19753.35651.14533.08273.23315.63
Loans and Advances 541.17313.2343.3171.73163.03186.14211.878.4880.9149.35
Total Current Assets4,571.326,888.345,689.575,123.072,846.292,357.461,850.981,408.151,071.9855.48
Current Liabilities 381.12698.17538.93458.34329.93518.27363.11250.7219.68154.38
Provisions 32.0731.3242.7553.8228.213.8915.012.237.120.5
Total Current Liabilities & Provisions413.19729.49581.68512.16358.13532.15378.12252.93226.8154.89
Net Current Assets4,158.146,158.855,107.894,610.92,488.151,825.311,472.861,155.22845.1700.6
Deferred Tax Assets8.2822.717.656.026.051.631.290.9400.39
Deferred Tax Liability116.54106.9295.4179.980.1109.2697.0486.3165.0442.73
Net Deferred Tax-108.26-84.21-87.76-73.88-74.05-107.63-95.75-85.37-65.04-42.34
Other Assets770.3128.92288.680.483.18113.2235.8432.8624.2561.78
Total Assets9,019.657,959.487,164.75,910.013,653.852,882.812,454.472,135.441,794.461,560.91
Contingent Liabilities15.5822.0712.7674.711.8321.17083.9946.77.66

Cash Flow (Figures in Rs. Crores)

Net Profit before Tax and Extr...1,132.54
Depreciation344.57
Interest (Net)-128.82
P/L on Sales of Assets-0.25
Prov. and W/O (Net)21.42
P/L in Forex-12.97
Total Adjustments (PBT and Ext...223.6
Operating Profit before Workin...1,356.15
Trade and 0ther Receivables-324.96
Inventories666.08
Trade Payables-378.87
Loans and Advances-5.1
Total Adjustments (OP before W...-53.2
Cash Generated from/(used in) ...1,302.95
Direct Taxes Paid-306.15
Total Adjustments(Cash Generat...-306.15
Cash Flow before Extraordinary...996.8
Net Cash from Operating Activi...996.8
Purchased of Fixed Assets-398.26
Sale of Fixed Assets0.77
Purchase of Investments-264.99
Sale of Investments265.34
Interest Received137.05
Acquisition of Companies-1,021.76
Net Cash used in Investing Act...-1,749.19
Proceeds from Issue of shares ...0.53
Proceed from 0ther Long Term B...21.03
Of the Long Tem Borrowings-777.31
Of Financial Liabilities-18.05
Interest Paid-25.61
Net Cash used in Financing Act...-799.42
Net Profit before Tax and Extr...1,405.5
Depreciation162.11
Interest (Net)-142.37
P/L on Sales of Assets0.88
P/L on Sales of Invest-0.35
Prov. and W/O (Net)11.74
P/L in Forex-8.85
Total Adjustments (PBT and Ext...23.15
Operating Profit before Workin...1,428.65
Trade and 0ther Receivables-317.53
Inventories685.09
Trade Payables-296.85
Loans and Advances-24.22
Total Adjustments (OP before W...23.38
Cash Generated from/(used in) ...1,452.02
Direct Taxes Paid-316.05
Total Adjustments(Cash Generat...-316.05
Cash Flow before Extraordinary...1,135.97
Net Cash from Operating Activi...1,135.97
Purchased of Fixed Assets-236.92
Sale of Fixed Assets0.15
Purchase of Investments-264.99
Sale of Investments265.34
Interest Received165.14
Invest.In Subsidiaires-2,377.58
Net Cash used in Investing Act...-2,917.58
Proceeds from Issue of shares ...0.53
Of the Long Tem Borrowings-0.56
Of Financial Liabilities-0.23
Interest Paid-7.14
Net Cash used in Financing Act...-7.4

Company Details

Registered Office
AddressSy No 143-148 150&151 Nr Gandi,
X Roads D P Pally Dundigal
CityHyderabad
StateTelangana
Pin Code500043
Tel. No.91-40-30510999
Fax. No.91-40-30510800
Emailinvestors@glandpharma.com
Internethttp://www.glandpharma.com
Registrars
AddressSy No 143-148 150&151 Nr Gandi
CityHyderabad
StateTelangana
Pin Code500043
Tel. No.91-40-30510999
Fax. No.91-40-30510800
Emailinvestors@glandpharma.com
Internethttp://www.glandpharma.com
Management
Name Designation
Yiu Kwan Stanley LauChairman & Independent Directo
SRINIVAS SADUManaging Director & CEO
UDO JAHANNES VETTERNon-Exec & Non-Independent Dir
C S N MurthyIndependent Director
ESSAJI GOOLAM VAHANVATIIndependent Director
Naina Lal KidwaiIndependent Director
Jia Ai (Allen) ZhangNon-Exec & Non-Independent Dir
Wenjie ZhangNon Executive Director
Wei HuangAdditional Director